Maxion Therapeutics

0 followers


Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.

Headquarters

Cambridge , GB

Employees

11-50

Links

Org chart

Arndt Schottelius

Collapse
John Mccafferty
Co-founder And CTO
Sohaib Mir
Senior Investment Principal
Thomas Weaver
Non-executive Director
Aneesh Karatt Vellatt
Chief Scientific Officer, Board Director
Sylwia Mankowska
Director Of Operations
Lisa Negus
Financial Controller
Lucy Edwardes Jones
Board Director

Teams

This company has no teams yet